…And The
Royal Academy
When Scientific Integrity
Yields to Financial Incentive
If medical researchers today were to rely on experiments conducted by individuals or institutions who stood to gain financially from the results, their conclusions would be dismissed out of hand. This is an academic standard applied across every field of science.
Stanford University’s conflict‑of‑interest guidelines state that personal financial gain must not influence research integrity, and if it does, it must be managed or eliminated. The International Committee of Medical Journal Editors requires that drug testing be conducted independently from those who stand to benefit. Modern academic ethics warn that financial incentives inherently bias results and undermine trust.
And yet, when we examine the foundations of modern theoretical physics, particularly the sponsoring and celebration of Maxwell’s equations and the 1919 eclipse validation of Einstein, we find a profound double standard handed down by the Royal Society and affiliated academies.
Two Presidents of the Royal Society, each with considerable private financial interests tied to British government and industrial enterprises, played critical roles.
Sir Robert Robinson, who served as President from 1945 to 1947, had deep associations with chemical and wartime industries that greatly profited from nuclear and electromagnetic research. His position gave him a direct interest in ensuring physics, especially anything tied to radiation, remained aligned with institutional funding flows.
Sir Humphry Davy, who held office from 1812 to 1819, maintained commercial interests in mining and chemical patents. He helped elevate Maxwell’s theoretical framework, which eventually powered telegraphy and later electrical industry expansion, industries in which individuals like Davy had investable stakes before academic endorsements were even formalized.
These were not neutral endorsements. These were institutional leaders who stood to gain financially from the elevation of electromagnetism and nuclear physics, before commissioning Maxwell or validating experiments like the 1919 eclipse expedition.
When Sir Arthur Eddington was appointed to lead the 1919 eclipse study, organized and funded by the Royal Society, the leadership did not merely support scientific curiosity. They were validating a theory with direct, global ramifications for science policy, prestige and state-funded research programs. Many of those programs would eventually funnel into nuclear development and defense industries, industries in which Royal Society leadership had clear personal interests.
This is a textbook case of conflict of interest. The Royal Society controlled grants directed to eclipse expeditions, Maxwell’s electromagnetic research and early nuclear science. Its leadership had financial ties to industries contextualized and elevated by the science they oversaw. The success of Einstein, Maxwell and Eddington did not just validate theories, they opened floodgates to funding, institutional growth and personal gain for those in power.
If the standards applied in medicine had been followed, this entire enterprise would be deemed invalid. Yet, in physics, these conflicts are recast as historical triumphs. That is not oversight. That is favoritism entrenched by wealth, influence and academic prestige.
Science bought is science compromised. Decisions made in these halls were not purely about discovery, they were about reward and reputation. And when the stakes are that high, trust becomes the first casualty.
Produced by The Lilborn Equation Team:
Michael Lilborn-Williams
Daniel Thomas Rouse
Thomas Jackson Barnard
Audrey Williams